Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Bangard

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Blood|July 13, 2012
Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experienceAchim Rothe, Stephanie Sasse, Helen Goergen, et al.
Neuro-Oncology|September 23, 2008
Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphomaMichael Linnebank, Susanna Moskau, Annika Jürgens, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2009
Downregulation of 18F-FDG uptake in PET as an early pharmacodynamic effect in treatment of non-small cell lung cancer with the mTOR inhibitor everolimusLucia Nogová, Ronald Boellaard, Carsten Kobe, et al.
Journal of Neuro-Oncology|October 22, 2008
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II studyHendrik Pels, Annika Juergens, Axel Glasmacher, et al.
Stroke|July 25, 2019
Functional Outcome Following Stroke Thrombectomy in Clinical PracticeFrank A Wollenweber, Steffen Tiedt, Anna Alegiani, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Blood|July 13, 2012
Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experienceAchim Rothe, Stephanie Sasse, Helen Goergen, et al.
Neuro-Oncology|September 23, 2008
Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphomaMichael Linnebank, Susanna Moskau, Annika Jürgens, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2009
Downregulation of 18F-FDG uptake in PET as an early pharmacodynamic effect in treatment of non-small cell lung cancer with the mTOR inhibitor everolimusLucia Nogová, Ronald Boellaard, Carsten Kobe, et al.
Journal of Neuro-Oncology|October 22, 2008
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II studyHendrik Pels, Annika Juergens, Axel Glasmacher, et al.
Stroke|July 25, 2019
Functional Outcome Following Stroke Thrombectomy in Clinical PracticeFrank A Wollenweber, Steffen Tiedt, Anna Alegiani, et al.
Pageof 4